Herbal Therapy

Title Average Ratingsort ascending
Why is not Ukrain approved yet in Austria/EU? 98.57%
Ukrain (NSC-631570) in the treatment of pancreas cancer. 95.00%
Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract. 95.00%
Study of the effects of vinpocetin on cognitive functions 90.00%
Clinical Investigations on Ukrain 90.00%
Effects of CANELIM capsule drug-contained serum on viscoelasticity 90.00%
Ukrain - a new cancer cure? A systematic review of randomised clinical trials. 90.00%
Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors 90.00%
Hibiscus sabdariffa L. Tea (Tisane) Lowers Blood Pressure in Prehypertensive and Mildly Hypertensive Adults 90.00%
Boswellia serrata acts on cerebral edema in patients irradiated for brain tumors: a prospective, randomized, placebo-controlled, 90.00%
Debate in Lancet about setting up a phase II trial on Ukrain in England 90.00%
Medicinal plants and cancer chemoprevention. 90.00%
WHO’S AFRAID OF A CURE FOR CANCER? - The struggle for an alternative cancer drug 90.00%
Mistletoe therapy in oncology 90.00%
Artemisinin derivates in the treatment of Cancer 90.00%
Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador). 90.00%
NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial 85.00%
Hypericine 83.33%
Mistletoe Therapy in Cancer 83.33%
Complementary and alternative medicines taken by cancer patients 80.00%
Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer. 80.00%
An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis. 80.00%
Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy – case report and review of literat 80.00%
Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador) 80.00%
Synergistic activity of PHY906 with capecitabine in pancreatic carcinoma. 80.00%
Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions. 80.00%
A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort 80.00%
Ukrain: Debated Subjects 80.00%
Ukrain Debate 1: What is the active Substance of Ukrain? 80.00%
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. 80.00%
Dramatic prostate-specific antigen response with activated hemicellulose compound in metastatic castration-resistant prostate ca 80.00%
In vitro screening for the tumoricidal properties of international medicinal herbs 80.00%
Resveratrol 80.00%
Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer 80.00%
Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled m 80.00%
Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort 80.00%
A lipoxygenase inhibitor in breast cancer brain metastases. 80.00%
Comparative evaluation of the complex treatment of rectal cancer patients (chemotherapy and X-ray therapy, Ukrain monotherapy) 80.00%
Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma 80.00%
Ukrain therapy of recurrent breast cancer with lung metastases (case report) 80.00%
Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled 80.00%
The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer. 75.00%
Ukrain treatment in a patient with breast carcinoma 70.00%
Ukrain treatment in carcinoma of the oesophagus (case report) 70.00%
Inhibitory effect of modified citrus pectin on liver metastases in a mouse colon cancer model. 70.00%
The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial. 70.00%
Curcumin 70.00%
Green Tea extract 70.00%
Efficacy of ukrain in the treatment of pancreatic cancer. 70.00%
Hibiscus as medical herb Hibiscus sabdariffa L. 70.00%
A Phase I/IIA, Multicenter, Double-Blind, Randomized, Placebo-Controlled, Crossover, Dose-Escalation, Safety Study of the Chemot 70.00%
Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. 70.00%
Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells. 70.00%
Medical Cannabis Compounds 70.00%
Garlic, or Allium sativum: a review of its potential use as an anti-cancer agent. 70.00%
Safety and Efficacy of Tien-Hsien Liquid Practical in Patients with Refractory Metastatic Breast Cancer: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase IIa Trial 70.00%
Preliminary results of individual therapy of chronic hepatitis C by Ukrain and interferon-alpha. 70.00%
Influence of Hypericum perforatum extract and its single compounds on amyloid-beta mediated toxicity in microglial cells. 70.00%
Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. 65.00%
Evaluation of Ukrain as an immunostimulant in patients with various carcinomas. 63.33%
Chelidonium majus L. (Ukrain) in the treatment of cancer patients. 63.33%
Ukrain 62.22%
Gallic acid, a major component of Toona sinensis leaf extracts, contains a ROS-mediated anti-cancer activity in human prostate 60.00%
Pycnogenol may alleviate adverse effects in oncologic treatment. 60.00%
Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. 60.00%
Boswellia 60.00%
Ukrain both as an anti cancer and immunoregulatory agent 60.00%
Is there a role for herbal medicine in the treatment of pancreatic cancer?. Highlights from the "44th ASCO Annual Meeting". 60.00%
Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symp 60.00%
Combined therapy with Ukrain and chemotherapy in ovarian cancer (case report) 60.00%
The effects of thiophosphoric acid (Ukrain) on cervical cancer, stage IB bulky 60.00%
Ukrain therapy of stage T1N0M0 bladder cancer patients 60.00%
Ukrain treatment in carcinoma of the cervix (case report) 60.00%
Biophysiological effects of Ukrain therapy in a patient with breast cancer (case report) 60.00%
New biochemical mechanisms of the anticancer effect of Ukrain in the treatment of cancer of the urinary bladder 60.00%
Beta-solamarine: tumor inhibitor isolated from Solanum dulcamara. 60.00%
Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid 55.00%
Propolis Extract (Bio 30) Suppresses the Growth of Human Neurofibromatosis (NF) Tumor Xenografts in Mice 55.00%
Ukrain treatment in a patient with metastatic renal cell carcinoma extending to the vena cava inferior. 50.00%
Results of Ukrain monotherapy of prostate cancer 50.00%
Ukrain with chemotherapy in malignant melanoma (case report) 50.00%
Ukrain in the treatment of urethral recurrent carcinoma (case report) 50.00%
Annonacin, a mono-tetrahydrofuran acetogenin, arrests cancer cells at the G1 phase and causes cytotoxicity in a Bax- and caspase 50.00%
Adjuvant simultaneous mistletoe chemotherapy in breast cancer--influence on immunological parameters, quality of life and tolera 50.00%
Ukrain treatment in a patient with non-seminomatous germ-cell tumour of testis (case report) 50.00%
Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, 50.00%
Adjuvante simultane Mistel-/Chemotherapie bei Mammakarzinom – Einfluss auf Immunparameter, Lebensqualität und Verträglichkeit 50.00%
Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus u 50.00%
A Phase I study of the safety of the nutritional supplement, active hexose correlated compound, AHCC, in healthy volunteers. 50.00%
Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies.... 50.00%
Die Rolle von Boswellia-Säuren in der Therapie maligner Gliome: Methodische Mängel 50.00%
Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report) 40.00%
Mistletoe in conventional oncological practice: exemplary cases. 40.00%
Ukrain treatment of a patient with retroperitoneal synovial sarcoma. 35.00%
Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain. 20.00%
Cancer Treatments 20.00%
Mistletoe as a treatment for cancer. Has no proved benefit, and can cause harm 20.00%
Herbal Based Cancer Therapies 10.00%
The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing 0.00%
Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment. 0.00%

Pages